Viewing Study NCT04852692


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-01-05 @ 6:37 PM
Study NCT ID: NCT04852692
Status: TERMINATED
Last Update Posted: 2025-05-23
First Post: 2021-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
Sponsor: Janssen Korea, Ltd., Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module